An accompanying letter reminds general practices and community pharmacy teams of the clinical recommendations on the most effective flu vaccine for 2018/19 for different patient groups. Adjuvanted trivalent influenza vaccine (aTIV) should be offered to all those aged 65 and over, whilst adults aged under 65 in clinical at-risk groups should be offered a quadrivalent influenza vaccine.